Cumberland Pharmaceuticals Inc(CPIX) Price Forecast & Company Analysis. P/E · Dividend · Earnings · Price Target · RSI · MACD | US Stocks Today
Nov 5 at 7:46 PM ET (Korea 11/6 09:46)
Full metrics table
| Index | - | P/E | - | EPS (ttm) | -0.73 | Insider Own | 41.6% | Shs Outstand | 15.0M | Perf Week | 15.17% |
| Market Cap | 0.08B | Forward P/E | - | EPS next Y | - | Insider Trans | - | Shs Float | 8.8M | Perf Month | -27.29% |
| Enterprise Value | 0.08B | PEG | - | EPS next Q | - | Inst Own | 16.57% | Short Float | 3.84% | Perf Quarter | -35.77% |
| Income | -0.01B | P/S | 2.4 | EPS this Y | - | Inst Trans | -6.57% | Short Ratio | 3.83 | Perf Half Y | 50.6% |
| Sales | 0.03B | P/B | 4.3 | EPS next 5Y | - | ROA | -14.91% | Short Interest | 0.34M | Perf YTD | 62.33% |
| Book/sh | 1.16 | P/C | 19.45 | EPS past 3/5Y | 20.68% 2.82% | ROE | -42.92% | 52W High | -46.01% ($9.28) | Perf Year | 177.29% |
| Cash/sh | 0.26 | P/FCF | 110.38 | Sales past 3/5Y | 1.95% 3.52% | ROIC | -50.43% | 52W Low | 249.23% ($1.43) | Perf 3Y | 219.84% |
| Dividend Est. | - | EV/EBITDA | - | EPS Y/Y TTM | -244.92% | Gross Margin | 86.22% | Volatility(W/M) | 11.3% 13.88% | Perf 5Y | 141.07% |
| Dividend TTM | - | EV/Sales | 2.42 | Sales Y/Y TTM | -25.68% | Oper. Margin | -29.58% | ATR (14) | 0.73 | Perf 10Y | 30% |
| Dividend Ex-Date | 2026/8/3 | Quick Ratio | 0.96 | EPS Q/Q | -476.57% | Profit Margin | -34.92% | RSI (14) | 41.03 | Recom | 1 |
| Dividend Gr. 3/5Y | - | Current Ratio | 0.96 | Sales Q/Q | -98.46% | SMA20 | -19.45% ($6.22) | Beta | 0.3 | Target Price | $9.75 |
| Payout | - | Debt/Eq | 0.27 | Earnings | 2026/11/10 | SMA50 | -26.54% ($6.82) | Rel Volume | 3.24 | Prev Close | $4.44 |
| Employees | 93 | LT Debt/Eq | 0.24 | EPS/Sales Surpr. | - | SMA200 | 3.96% ($4.82) | Avg Volume(3M) | 0.09M | Price | $5.01 |
| IPO | 2009/8/11 | Option/Short | Yes/Yes | Trades | 914 | Volume | 284,301 | Change | 12.84% |
Cumberland Pharmaceuticals is a specialty pharmaceutical company headquartered in Nashville, Tennessee, USA. It acquires, develops, and markets branded prescription drugs in the areas of hospital acute care, gastroenterology, rheumatology, and oncology, supplying approved products through its hospital, field, and oncology sales organizations across the United States. Recently, the company has been shifting its focus toward a rare disease pipeline alongside the reshaping of its commercial portfolio.
Over the past 1 year, roughly in the middle
46% below its 1-year high.
Traded more than usual. That is 324% of its average volume.
Next earnings report: November 10
4 days to go.
CPIX has weak earning power
Of every $100 in sales, $29.58 is lost.
Tap to view numbers
Relative to sales, the price is about the industry average
Loss-making, so we compare on sales. For a company selling $100 a year, you would pay $240. Peers typically go for $177.
Tap to view numbers
It has beaten expectations every time
Beat market estimates in the last 4 quarters.
Tap to view numbers
Opinions on the outlook are split
Analyst sentiment is Strong Buy.
Tap to view numbers
Holding long would have paid off
Bought 5 years ago, your return today would be +141.1%. The S&P 500 did +56% over the same period.
Tap to view numbers
No dividend
There is no profit to distribute yet.
Ownership is about average
Institutions hold 16.6%.
Tap to view numbers
Multiple ETFs hold this stock, but only a sliver
Buying this ETF gives you exposure to this stock as well.
It ranks #58 of 83 in the industry
Based on market cap of $75M.
AKBA#55 Akebia Therapeutics Inc $118M PER - 
CRDL#56 Cardiol Therapeutics Inc $112M PER - 
ORGO#57 Organogenesis Holdings Inc $108M PER - CPIX#58 Cumberland Pharmaceuticals Inc $75M PER - 
TLPH#59 Talphera Inc $52M PER - 
FAQ
What kind of company is CPIX?
CPIX belongs to the Healthcare sector and operates in the Drug Manufacturers - Specialty & Generic industry.
What is the market cap of CPIX?
The market cap of CPIX is approximately $75M, ranking 4,636 within its sector.
What is the 52-week high and low for CPIX?
CPIX has recorded a 52-week high of $9.28 and a low of $1.43.
